Profiling plasma extracellular vesicle by pluronic block-copolymer based enrichment method unveils features associated with breast cancer aggression, metastasis and invasion

References

• Orozco AF, Lewis DE. Flow cytometric analysis of circulating microparticles in plasma. Cytometry A. 2010;77:1–23.
   Google Scholar
• Stoorvogel W, Kleijmeer MJ, Geuze HJ, et al. The biogenesis and functions of exosomes. Traffic. 2002;3:321–330.
   PubMed Web of Science ®Google Scholar
• Livshits MA, Khomyakova E, Evtushenko EG, et al. Isolation of exosomes by differential centrifugation: theoretical analysis of a commonly used protocol. Sci Rep. 2015;5:17319.
   PubMed Web of Science ®Google Scholar
• Thery C, Amigorena S, Raposo G, et al. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol. 2006;30 (1):3.22.1–3.22.29.
   PubMedGoogle Scholar
• Antes TJ, Kwei K. Methods for microvesicle isolation and selective removal. System Biosciences LLC, US20130337440A1; 2013.
   Google Scholar
• Helwa I, Cai J, Drewry MD, et al. A comparative study of serum exosome isolation using differential ultracentrifugation and three commercial reagents. PLoS One. 2017;12:e0170628.
   PubMed Web of Science ®Google Scholar
• Caradec J, Kharmate G, Hosseini-Beheshti E, et al. Reproducibility and efficiency of serum-derived exosome extraction methods. Clin Biochem. 2014;47:1286–1292.
   PubMed Web of Science ®Google Scholar
• Van Deun J, Mestdagh P, Sormunen R, et al. The impact of disparate isolation methods for extracellular vesicles on downstream RNA profiling. J Extracell Vesicles. 2014;32858.
   Google Scholar
• Kabanov AV, Lemieux P, Vinogradov S, et al. Pluronic block copolymers: novel functional molecules for gene therapy. Adv Drug Deliv Rev. 2002;54:223–233.
   PubMed Web of Science ®Google Scholar
• Shelat PB, Plant LD, Wang JC, et al. The membrane-active tri-block copolymer pluronic F-68 profoundly rescues rat hippocampal neurons from oxygen-glucose deprivation-induced death through early inhibition of apoptosis. J Neurosci. 2013;33:12287–12299.
   Web of Science ®Google Scholar
• Firestone MA, Wolf AC, Seifert S. Small-angle X-ray scattering study of the interaction of poly(ethylene oxide)-b-poly(propylene oxide)-b-poly(ethylene oxide) triblock copolymers with lipid bilayers. Biomacromolecules. 2003;4:1539–1549.
   PubMed Web of Science ®Google Scholar
• Lee RC, River LP, Pan FS, et al. Surfactant-induced sealing of electropermeabilized skeletal muscle membranes in vivo. Proc Natl Acad Sci U S A. 1992;89:4524–4528.
   PubMed Web of Science ®Google Scholar
• Marks JD, Pan CY, Bushell T, et al. Amphiphilic, tri-block copolymers provide potent membrane-targeted neuroprotection. Faseb J. 2001;15:1107–1109.
   PubMedGoogle Scholar
• Melnichenko AA, Aksenov DV, Myasoedova VA, et al. Pluronic block copolymers inhibit low density lipoprotein self-association. Lipids. 2012;47:995–1000.
   Web of Science ®Google Scholar
• Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9:671–675.
   PubMed Web of Science ®Google Scholar
• Trapnell C, Williams BA, Pertea G, et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol. 2010;28:511–515.
   PubMed Web of Science ®Google Scholar
• Rekker K, Saare M, Roost AM, et al. Circulating microRNA Profile throughout the menstrual cycle. PLoS One. 2013;8:e81166.
   PubMed Web of Science ®Google Scholar
• Chambers MC, Maclean B, Burke R, et al. A cross-platform toolkit for mass spectrometry and proteomics. Nat Biotechnol. 2012;30:918–920.
   PubMed Web of Science ®Google Scholar
• Kim S, Pevzner PA. MS-GF+ makes progress towards a universal database search tool for proteomics. Nat Commun. 2014;5:5277.
   PubMed Web of Science ®Google Scholar
• Krey JF, Wilmarth PA, Shin JB, et al. Accurate label-free protein quantitation with high- and low-resolution mass spectrometers. J Proteome Res. 2014;13:1034–1044.
   PubMed Web of Science ®Google Scholar
• Sardiu ME, Washburn MP. Enriching quantitative proteomics with SI(N). Nat Biotechnol. 2010;28:40–42.
   Web of Science ®Google Scholar
• Lotvall J, Hill AF, Hochberg F, et al. Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles. J Extracell Vesicles. 2014;3:26913.
   PubMedGoogle Scholar
• Ohshima K, Inoue K, Fujiwara A, et al. Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line. PLoS One. 2010;5:e13247.
   PubMed Web of Science ®Google Scholar
• Hannafon BN, Carpenter KJ, Berry WL, et al. Exosome-mediated microRNA signaling from breast cancer cells is altered by the anti-angiogenesis agent docosahexaenoic acid (DHA). Mol Cancer. 2015;14:133.
   PubMed Web of Science ®Google Scholar
• Zhang J, Li S, Li L, et al. Exosome and exosomal microRNA: trafficking, sorting, and function. Genomics Proteomics Bioinformatics. 2015;13:17–24.
   PubMed Web of Science ®Google Scholar
• Hortin GL, Sviridov D, Anderson NL. High-abundance polypeptides of the human plasma proteome comprising the top 4 logs of polypeptide abundance. Clin Chem. 2008;54:1608–1616.
   PubMed Web of Science ®Google Scholar
• Thery C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol. 2002;2:569–579.
   PubMed Web of Science ®Google Scholar
• Badimon L, Suades R, Fuentes E, et al. Role of platelet-derived microvesicles as crosstalk mediators in atherothrombosis and future pharmacology targets: a link between inflammation, atherosclerosis, and thrombosis. Front Pharmacol. 2016;7:293.
   Web of Science ®Google Scholar
• Ge R, Tan E, Sharghi-Namini S, et al. Exosomes in cancer microenvironment and beyond: have we overlooked these extracellular messengers? Cancer Microenviron. 2012;5:323–332.
   PubMedGoogle Scholar
• Buschow SI, van Balkom BW, Aalberts M, et al. MHC class II-associated proteins in B-cell exosomes and potential functional implications for exosome biogenesis. Immunol Cell Biol. 2010;88:851–856.
   PubMed Web of Science ®Google Scholar
• Keerthikumar S, Chisanga D, Ariyaratne D, et al. ExoCarta:a web-based compendium of exosomal cargo. J Mol Biol. 2016;428:688–692.
   PubMed Web of Science ®Google Scholar
• van Balkom BW, Eisele AS, Pegtel DM, et al. Quantitative and qualitative analysis of small RNAs in human endothelial cells and exosomes provides insights into localized RNA processing, degradation and sorting. J Extracell Vesicles. 2015;4:26760.
   PubMed Web of Science ®Google Scholar
• Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol. 2013;200:373–383.
   PubMed Web of Science ®Google Scholar
• Hewson C, Capraro D, Burdach J, et al. Extracellular vesicle associated long non-coding RNAs functionally enhance cell viability. Noncoding RNA Res. 2016;1:3–11.
   Google Scholar
• Khurana R, Ranches G, Schafferer S, et al. Identification of urinary exosomal noncoding RNAs as novel biomarkers in chronic kidney disease. Rna. 2017;23:142–152.
   PubMed Web of Science ®Google Scholar
• Shore S, Henderson JM, Lebedev A, et al. Small RNA library preparation method for next-generation sequencing using chemical modifications to prevent adapter dimer formation. PLoS One. 2016;11:e0167009.
   PubMed Web of Science ®Google Scholar
• Venkatesh T, Suresh PS, Tsutsumi R. tRFs: miRNAs in disguise. Gene. 2016;579:133–138.
   PubMed Web of Science ®Google Scholar
• Hizir Z, Bottini S, Grandjean V, et al. RNY (YRNA)-derived small RNAs regulate cell death and inflammation in monocytes/macrophages. Cell Death Dis. 2017;8:e2530.
   PubMed Web of Science ®Google Scholar
• Ung TH, Madsen HJ, Hellwinkel JE, et al. Exosome proteomics reveals transcriptional regulator proteins with potential to mediate downstream pathways. Cancer Sci. 2014;105:1384–1392.
   Web of Science ®Google Scholar
• Liang H, Gong F, Zhang S, et al. The origin, function, and diagnostic potential of extracellular microRNAs in human body fluids. Wiley Interdiscip Rev RNA. 2014;5:285–300.
   PubMed Web of Science ®Google Scholar
• Huang X, Yuan T, Tschannen M, et al. Characterization of human plasma-derived exosomal RNAs by deep sequencing. BMC Genomics. 2013;14:319.
   PubMed Web of Science ®Google Scholar
• Sugiura A, McLelland GL, Fon EA, et al. A new pathway for mitochondrial quality control: mitochondrial-derived vesicles. EMBO J. 2014;33:2142–2156.
   PubMed Web of Science ®Google Scholar
• Holliday DL, Speirs V. Choosing the right cell line for breast cancer research. Breast Cancer Res. 2011;13:215.
   PubMed Web of Science ®Google Scholar
• Soule HD, Vazguez J, Long A, et al. A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst. 1973;51:1409–1416.
   PubMed Web of Science ®Google Scholar
• Brinkley BR, Beall PT, Wible LJ, et al. Variations in cell form and cytoskeleton in human breast carcinoma cells in vitro. Cancer Res. 1980;40:3118–3129.
   Web of Science ®Google Scholar
• Cailleau R, Olive M, Cruciger QV. Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization. In Vitro. 1978;14:911–915.
   PubMedGoogle Scholar
• Keydar I, Chen L, Karby S, et al. Establishment and characterization of a cell line of human breast carcinoma origin. Eur J Cancer. 1979;15:659–670.
   PubMed Web of Science ®Google Scholar
• Fantozzi A, Christofori G. Mouse models of breast cancer metastasis. Breast Cancer Res. 2006;8:212.
   PubMed Web of Science ®Google Scholar
• Uhlen M, Fagerberg L, Hallstrom BM, et al. Proteomics. Tissue-based map of the human proteome. Science. 2015;347:1260419.
   PubMed Web of Science ®Google Scholar
• Uhlen M, Oksvold P, Fagerberg L, et al. Towards a knowledge-based Human Protein Atlas. Nat Biotechnol. 2010;28:1248–1250.
   PubMed Web of Science ®Google Scholar
• Uhlen M, Bjorling E, Agaton C, et al. A human protein atlas for normal and cancer tissues based on antibody proteomics. Mol Cell Proteomics. 2005;4:1920–1932.
   PubMed Web of Science ®Google Scholar
• Oliveira NC, Gomig TH, Milioli HH, et al. Comparative proteomic analysis of ductal and lobular invasive breast carcinoma. Genet Mol Res. 2016;15(2): gmr.15027701.
   Web of Science ®Google Scholar
• Li Y, Rong G, Kang H. Taxotere-induced elevated expression of IL8 in carcinoma-associated fibroblasts of breast invasive ductal cancer. Oncol Lett. 2017;13:1856–1860.
   Web of Science ®Google Scholar
• Liu YL, Zhang HM, Pan HM, et al. The relationship between apolipoprotein E gene epsilon2/epsilon3/epsilon4 polymorphism and breast cancer risk: a systematic review and meta-analysis. Onco Targets Ther. 2016;9:1241–1249.
   Web of Science ®Google Scholar
• Stevens KN, Wang X, Fredericksen Z, et al. Evaluation of associations between common variation in mitotic regulatory pathways and risk of overall and high grade breast cancer. Breast Cancer Res Treat. 2011;129:617–622.
   Web of Science ®Google Scholar
• Lucci MA, Orlandi R, Triulzi T, et al. Expression profile of tyrosine phosphatases in HER2 breast cancer cells and tumors. Cell Oncol. 2010;32:361–372.
   Web of Science ®Google Scholar
• Russo J, Russo IH. Molecular basis of pregnancy-induced breast cancer prevention. Horm Mol Biol Clin Investig. 2012;9:3–10.
   Google Scholar
• Chu X, Guo X, Jiang Y, et al. Genotranscriptomic meta-analysis of the CHD family chromatin remodelers in human cancers - initial evidence of an oncogenic role for CHD7. Mol Oncol. 2017;11:1348–1360.
   PubMed Web of Science ®Google Scholar
• Faraji F, Hu Y, Wu G, et al. An integrated systems genetics screen reveals the transcriptional structure of inherited predisposition to metastatic disease. Genome Res. 2014;24:227–240.
   Web of Science ®Google Scholar
• Gonzalez-Conchas GA, Rodriguez-Romo L, Hernandez-Barajas D, et al. Epidermal growth factor receptor overexpression and outcomes in early breast cancer: a systematic review and a meta-analysis. Cancer Treat Rev. 2017;62:1–8.
   Web of Science ®Google Scholar
• Qian W, Tao L, Wang Y, et al. Downregulation of integrins in cancer cells and anti-platelet properties are involved in holothurian glycosaminoglycan-mediated disruption of the interaction of cancer cells and platelets in hematogenous metastasis. J Vasc Res. 2015;52:197–209.
   Web of Science ®Google Scholar
• Chi Y, Huang S, Wang L, et al. CDK11p58 inhibits ERalpha-positive breast cancer invasion by targeting integrin beta3 via the repression of ERalpha signaling. BMC Cancer. 2014;14:577.
   Web of Science ®Google Scholar
• Gong Y, He T, Yang L, et al. The role of miR-100 in regulating apoptosis of breast cancer cells. Sci Rep. 2015;5:11650.
   PubMed Web of Science ®Google Scholar
• Marcotte R, Sayad A, Brown KR, et al. Functional genomic landscape of human breast cancer drivers, vulnerabilities, and resistance. Cell. 2016;164:293–309.
   PubMed Web of Science ®Google Scholar
• Abdelkarim M, Vintonenko N, Starzec A, et al. Invading basement membrane matrix is sufficient for MDA-MB-231 breast cancer cells to develop a stable in vivo metastatic phenotype. PLoS One. 2011;6:e23334.
   Web of Science ®Google Scholar
• Cine N, Baykal AT, Sunnetci D, et al. Identification of ApoA1, HPX and POTEE genes by omic analysis in breast cancer. Oncol Rep. 2014;32:1078–1086.
   Web of Science ®Google Scholar
• Qian L, Gao X, Huang H, et al. PRSS3 is a prognostic marker in invasive ductal carcinoma of the breast. Oncotarget. 2017;8:21444–21453.
   PubMedGoogle Scholar
• Ma R, Ye X, Cheng H, et al. PRSS3 expression is associated with tumor progression and poor prognosis in epithelial ovarian cancer. Gynecol Oncol. 2015;137:546–552.
   PubMed Web of Science ®Google Scholar
• Hockla A, Radisky DC, Radisky ES. Mesotrypsin promotes malignant growth of breast cancer cells through shedding of CD109. Breast Cancer Res Treat. 2010;124:27–38.
   PubMed Web of Science ®Google Scholar
• Yang L, Shi T, Liu F, et al. REV3L, a promising target in regulating the chemosensitivity of cervical cancer cells. PLoS One. 2015;10:e0120334.
   PubMed Web of Science ®Google Scholar
• Varadi V, Bevier M, Grzybowska E, et al. Genetic variation in genes encoding for polymerase zeta subunits associates with breast cancer risk, tumour characteristics and survival. Breast Cancer Res Treat. 2011;129:235–245.
   PubMed Web of Science ®Google Scholar
• Roger S, Gillet L, Le Guennec JY, et al. Voltage-gated sodium channels and cancer: is excitability their primary role? Front Pharmacol. 2015;6:152.
   PubMed Web of Science ®Google Scholar
• Gau DM, Lesnock JL, Hood BL, et al. BRCA1 deficiency in ovarian cancer is associated with alteration in expression of several key regulators of cell motility - A proteomics study. Cell Cycle. 2015;14:1884–1892.
   PubMed Web of Science ®Google Scholar
• Gur-Dedeoglu B, Konu O, Kir S, et al. A resampling-based meta-analysis for detection of differential gene expression in breast cancer. BMC Cancer. 2008;8:396.
   Web of Science ®Google Scholar
• Song J, Yang W, Shih IM, et al. Identification of BCOX1, a novel gene overexpressed in breast cancer. Biochim Biophys Acta. 2006;1760:62–69.
   Web of Science ®Google Scholar
• Schuetz CS, Bonin M, Clare SE, et al. Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis. Cancer Res. 2006;66:5278–5286.
   PubMed Web of Science ®Google Scholar
• Lee S, Stewart S, Nagtegaal I, et al. Differentially expressed genes regulating the progression of ductal carcinoma in situ to invasive breast cancer. Cancer Res. 2012;72:4574–4586.
   Web of Science ®Google Scholar
• Michael M, Begum R, Fong K, et al. BPAG1-e restricts keratinocyte migration through control of adhesion stability. J Invest Dermatol. 2014;134:773–782.
   Web of Science ®Google Scholar
• Kuchnio A, Dewerchin M, Carmeliet P. The PHD2 oxygen sensor paves the way to metastasis. Oncotarget. 2015;6:35149–35150.
   Google Scholar
• Bordoli MR, Stiehl DP, Borsig L, et al. Prolyl-4-hydroxylase PHD2- and hypoxia-inducible factor 2-dependent regulation of amphiregulin contributes to breast tumorigenesis. Oncogene. 2011;30:548–560.
   PubMed Web of Science ®Google Scholar
• Singh M, Devi U, Roy S, et al. Prolyl hydroxylase mediated inhibition of fatty acid synthase to combat tumor growth in mammary gland carcinoma. Breast Cancer. 2016;23:820–829.
   Web of Science ®Google Scholar
• Paolicchi E, Crea F, Farrar WL, et al. Histone lysine demethylases in breast cancer. Crit Rev Oncol Hematol. 2013;86:97–103.
   Web of Science ®Google Scholar
• Hou J, Wu J, Dombkowski A, et al. Genomic amplification and a role in drug-resistance for the KDM5A histone demethylase in breast cancer. Am J Transl Res. 2012;4:247–256.
   PubMed Web of Science ®Google Scholar
• Gale M, Sayegh J, Cao J, et al. Screen-identified selective inhibitor of lysine demethylase 5A blocks cancer cell growth and drug resistance. Oncotarget. 2016;7:39931–39944.
   PubMedGoogle Scholar
• Newbold RF, Mokbel K. Evidence for a tumour suppressor function of SETD2 in human breast cancer: a new hypothesis. Anticancer Res. 2010;30:3309–3311.
   Web of Science ®Google Scholar
• Al Sarakbi W, Sasi W, Jiang WG, et al. The mRNA expression of SETD2 in human breast cancer: correlation with clinico-pathological parameters. BMC Cancer. 2009;9:290.
   PubMed Web of Science ®Google Scholar
• Shen H, Li L, Zhou S, et al. The role of ADAM17 in tumorigenesis and progression of breast cancer. Tumour Biol. 2016;37(12):15359–15370.
   Google Scholar
• Narita D, Seclaman E, Ilina R, et al. ADAM12 and ADAM17 gene expression in laser-capture microdissected and non-microdissected breast tumors. Pathol Oncol Res. 2011;17:375–385.
   Web of Science ®Google Scholar
• Zheng X, Jiang F, Katakowski M, et al. ADAM17 promotes breast cancer cell malignant phenotype through EGFR-PI3K-AKT activation. Cancer Biol Ther. 2009;8:1045–1054.
   PubMed Web of Science ®Google Scholar
• Wang CY, Lai MD, Phan NN, et al. Meta-analysis of public microarray datasets reveals voltage-gated calcium gene signatures in clinical cancer patients. PLoS One. 2015;10:e0125766.
   PubMed Web of Science ®Google Scholar
• Yamaga R, Ikeda K, Horie-Inoue K, et al. RNA sequencing of MCF-7 breast cancer cells identifies novel estrogen-responsive genes with functional estrogen receptor-binding sites in the vicinity of their transcription start sites. Horm Cancer. 2013;4:222–232.
   Web of Science ®Google Scholar
• Bjorklund SS, Panda A, Kumar S, et al. Widespread alternative exon usage in clinically distinct subtypes of Invasive Ductal Carcinoma. Sci Rep. 2017;7:5568.
   Web of Science ®Google Scholar
• Wang H, Wang B, Zhu W, et al. Lentivirus-mediated knockdown of myosin VI inhibits cell proliferation of breast cancer cell. Cancer Biother Radiopharm. 2015;30:330–335.
   PubMed Web of Science ®Google Scholar
• De Marchi T, Timmermans AM, Smid M, et al. Annexin-A1 and caldesmon are associated with resistance to tamoxifen in estrogen receptor positive recurrent breast cancer. Oncotarget. 2016;7:3098–3110.
   Google Scholar
• Zou JX, Duan Z, Wang J, et al. Kinesin family deregulation coordinated by bromodomain protein ANCCA and histone methyltransferase MLL for breast cancer cell growth, survival, and tamoxifen resistance. Mol Cancer Res. 2014;12:539–549.
   PubMed Web of Science ®Google Scholar
• Yuasa-Kawada J, Kinoshita-Kawada M, Rao Y, et al. Deubiquitinating enzyme USP33/VDU1 is required for Slit signaling in inhibiting breast cancer cell migration. Proc Natl Acad Sci U S A. 2009;106:14530–14535.
   Web of Science ®Google Scholar
• Chen NP, Uddin B, Voit R, et al. Human phosphatase CDC14A is recruited to the cell leading edge to regulate cell migration and adhesion. Proc Natl Acad Sci U S A. 2016;113:990–995.
   PubMed Web of Science ®Google Scholar
• Sohn EJ, Jung DB, Lee H, et al. CNOT2 promotes proliferation and angiogenesis via VEGF signaling in MDA-MB-231 breast cancer cells. Cancer Lett. 2017;412:88–98.
   Web of Science ®Google Scholar
• Li W, Liu C, Zhao C, et al. Downregulation of beta3 integrin by miR-30a-5p modulates cell adhesion and invasion by interrupting Erk/Ets1 network in triple-negative breast cancer. Int J Oncol. 2016;48:1155–1164.
   Web of Science ®Google Scholar
• Carter RZ, Micocci KC, Natoli A, et al. Tumour but not stromal expression of beta3 integrin is essential, and is required early, for spontaneous dissemination of bone-metastatic breast cancer. J Pathol. 2015;235:760–772.
   Web of Science ®Google Scholar
• Liu T, Zhang XY, He XH, et al. High levels of BCOX1 expression are associated with poor prognosis in patients with invasive ductal carcinomas of the breast. PLoS One. 2014;9:e86952.
   Web of Science ®Google Scholar